Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

LEP continues in active development for oncology indications

May 11, 2001

Structurally novel class of antiangiogenic agents discussed at Trends in Drug Research meeting

May 11, 2001

Xenerex and Eos enter antibody research alliance

May 11, 2001

Mechanism of anticancer action of NB-1011 investigated

May 11, 2001

Etoposide and paclitaxel conjugates prepared by Nobex for improving drug delivery

May 10, 2001

AstraZeneca completes patient enrollment in NSCLC phase III trials of Iressa

May 10, 2001

Orally active Raf kinase inhibitor from Onyx/Bayer in phase I clinical trials

May 9, 2001

Potency of several retinoids assessed in bladder cancer cell lines

May 9, 2001

Enzon begins patient treatment in phase I trial of PEG-paclitaxel

May 9, 2001

MGI's lead acylfulvene advances to phase II for refractory sarcoma

May 9, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...